224 related articles for article (PubMed ID: 31420939)
1. Integrated systems-genetic analyses reveal a network target for delaying glioma progression.
Laaniste L; Srivastava PK; Stylianou J; Syed N; Cases-Cunillera S; Shkura K; Zeng Q; Rackham OJL; Langley SR; Delahaye-Duriez A; O'Neill K; Williams M; Becker A; Roncaroli F; Petretto E; Johnson MR
Ann Clin Transl Neurol; 2019 Sep; 6(9):1616-1638. PubMed ID: 31420939
[TBL] [Abstract][Full Text] [Related]
2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
3. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV.
Narsia N; Ramagiri P; Ehrmann J; Kolar Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):261-271. PubMed ID: 28452381
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional analysis of aggressiveness and heterogeneity across grades of astrocytomas.
Wang C; Funk CC; Eddy JA; Price ND
PLoS One; 2013; 8(10):e76694. PubMed ID: 24146911
[TBL] [Abstract][Full Text] [Related]
6. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction.
van den Boom J; Wolter M; Kuick R; Misek DE; Youkilis AS; Wechsler DS; Sommer C; Reifenberger G; Hanash SM
Am J Pathol; 2003 Sep; 163(3):1033-43. PubMed ID: 12937144
[TBL] [Abstract][Full Text] [Related]
7. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
8. Screening critical genes associated with malignant glioma using bioinformatics analysis.
Xu Y; Wang J; Xu Y; Xiao H; Li J; Wang Z
Mol Med Rep; 2017 Nov; 16(5):6580-6589. PubMed ID: 28901452
[TBL] [Abstract][Full Text] [Related]
9. Comparative transcriptomics reveals similarities and differences between astrocytoma grades.
Seifert M; Garbe M; Friedrich B; Mittelbronn M; Klink B
BMC Cancer; 2015 Dec; 15():952. PubMed ID: 26673168
[TBL] [Abstract][Full Text] [Related]
10. IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis.
Otani R; Uzuka T; Higuchi F; Matsuda H; Nomura M; Tanaka S; Mukasa A; Ichimura K; Kim P; Ueki K
Cancer Sci; 2018 Jul; 109(7):2327-2335. PubMed ID: 29752851
[TBL] [Abstract][Full Text] [Related]
11. CDC20 with malignant progression and poor prognosis of astrocytoma revealed by analysis on gene expression.
Ding Y; Yu S; Bao Z; Liu Y; Liang T
J Neurooncol; 2017 May; 133(1):87-95. PubMed ID: 28432586
[TBL] [Abstract][Full Text] [Related]
12. Genetic alterations associated with glioma progression.
Kleihues P; Lübbe J; Watanabe K; von Ammon K; Ohgaki H
Verh Dtsch Ges Pathol; 1994; 78():43-7. PubMed ID: 7534015
[TBL] [Abstract][Full Text] [Related]
13. Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.
Chai RC; Zhang KN; Chang YZ; Wu F; Liu YQ; Zhao Z; Wang KY; Chang YH; Jiang T; Wang YZ
Carcinogenesis; 2019 Oct; 40(10):1229-1239. PubMed ID: 31157866
[TBL] [Abstract][Full Text] [Related]
14. Molecular subtypes of glioma identified by genome-wide methylation profiling.
Kloosterhof NK; de Rooi JJ; Kros M; Eilers PH; Sillevis Smitt PA; van den Bent MJ; French PJ
Genes Chromosomes Cancer; 2013 Jul; 52(7):665-74. PubMed ID: 23629961
[TBL] [Abstract][Full Text] [Related]
15. Open Data for Differential Network Analysis in Glioma.
Jean-Quartier C; Jeanquartier F; Holzinger A
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952211
[TBL] [Abstract][Full Text] [Related]
16. Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma.
Ivliev AE; 't Hoen PA; Sergeeva MG
Cancer Res; 2010 Dec; 70(24):10060-70. PubMed ID: 21159630
[TBL] [Abstract][Full Text] [Related]
17. Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.
Pan Y; Duron C; Bush EC; Ma Y; Sims PA; Gutmann DH; Radunskaya A; Hardin J
PLoS One; 2018; 13(5):e0190001. PubMed ID: 29787563
[TBL] [Abstract][Full Text] [Related]
18. ACTB and SDHA Are Suitable Endogenous Reference Genes for Gene Expression Studies in Human Astrocytomas Using Quantitative RT-PCR.
Röhn G; Koch A; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818802318. PubMed ID: 30259794
[TBL] [Abstract][Full Text] [Related]
19. DMBT1 homozygous deletion in diffuse astrocytomas is associated with unfavorable clinical outcome.
Motomura K; Mittelbronn M; Paulus W; Brokinkel B; Keyvani K; Sure U; Wrede K; Nakazato Y; Tanaka Y; Pierscianek D; Kim YH; Mariani L; Vital A; Ohgaki H
J Neuropathol Exp Neurol; 2012 Aug; 71(8):702-7. PubMed ID: 22805772
[TBL] [Abstract][Full Text] [Related]
20. iASPP, a microRNA‑124 target, is aberrantly expressed in astrocytoma and regulates malignant glioma cell migration and viability.
Liu X; Kang J; Sun S; Luo Y; Ji X; Zeng X; Zhao S
Mol Med Rep; 2018 Jan; 17(1):1970-1978. PubMed ID: 29257240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
